2024年至2032年兽用抗感染药市场机会、成长动力、产业趋势分析与预测

2023年全球兽用抗感染药市场价值为54亿美元，预计2024年至2032年复合年增长率为3.5%。抗感染治疗对于控制细菌、病毒和真菌感染、预防可能导致农业重大经济损失的潜在疾病爆发至关重要。此外，它们还有助于改善伴侣动物的整体福祉，促进该行业对有效治疗的需求不断增长。

根据动物类型，市场分为两个部分：牲畜和伴侣动物。预计畜牧业将继续占据主导地位，在 2023 年占据最大的收入份额，并预计在整个预测期内以 3.4% 的成长率保持领先地位。这种主导地位是由大规模农业经营中疾病管理和预防的需求所驱动的。全球肉类需求的成长以及动物健康意识的提高，进一步推动了牲畜管理中抗感染解决方案的采用。

兽用抗感染药市场依产品类型进一步分类，包括抗菌药、抗霉菌药、抗病毒药和抗寄生虫药。其中，抗菌领域占有最大的市场份额，2023年将占44.3%，预计仍将维持领先地位。这是因为抗生素在解决牲畜和伴侣动物的细菌感染方面发挥关键作用。细菌性疾病的日益普及以及抗生素抗药性带来的持续挑战凸显了持续创新和研究开发抗菌治疗的重要性。

在北美，兽用抗感染药物市场可望大幅成长，其中美国到2023年将贡献20亿美元。美国也受益于严格的监管框架，确保抗感染产品的安全性和有效性，进一步鼓励产业成长。宠物拥有量的增加和对畜产品的需求不断增长，继续推动对兽用抗感染药物的需求，使美国成为全球市场的关键参与者。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 动物中人畜共通传染病的发生率上升
    • 兽药不断进步
    • 对肉类和动物产品的需求不断增加
    • 政府不断采取措施控制动物疾病
  • 产业陷阱与挑战
    • 对抗生素抗药性的担忧日益加剧
    • 严格的监管挑战
• 成长潜力分析
• 监管环境
• 管道分析
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按动物类型，2021 - 2032

• 主要趋势
• 畜牧动物
  • 牛
  • 家禽
  • 猪
  • 其他家畜动物
• 伴侣动物
  • 狗
  • 猫
  • 其他伴侣动物

第 6 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 抗菌
• 抗真菌剂
• 抗病毒药
• 抗寄生虫药

第 7 章：市场估计与预测：按管理途径，2021 - 2032 年

• 主要趋势
• 口服
• 注射用
• 专题
• 其他给药途径

第 8 章：市场估计与预测：按配销通路，2021 - 2032 年

• 主要趋势
• 零售药局
• 网路药局
• 兽医院药房

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋

第 10 章：公司简介

• Aspen Veterinary Resources
• Boehringer Ingelheim International
• Ceva
• Dechra Pharmaceuticals
• Elanco
• Merck & Co
• Norbrook
• Phibro Animal Health
• Vetoquinol SA
• Virbac
• Zoetis

The Global Veterinary Anti-infectives Market, valued at USD 5.4 billion in 2023, is expected to expand at a CAGR of 3.5% from 2024 to 2032. This growth is driven by the rising prevalence of infectious diseases in livestock and companion animals. Anti-infective treatments are essential for managing bacterial, viral, and fungal infections, preventing potential disease outbreaks that can result in significant economic losses in agriculture. Additionally, they help improve the overall well-being of companion animals, contributing to the growing demand for effective treatments in the sector.

The market is divided into two segments based on animal type: livestock and companion animals. The livestock segment is anticipated to remain dominant, holding the largest revenue share in 2023, and is projected to maintain its leadership throughout the forecast period with a growth rate of 3.4%. This dominance is driven by the need for disease management and prevention in large-scale farming operations. Rising global demand for meat, along with increased awareness of animal health, further propels the adoption of anti-infective solutions in livestock management.

The veterinary anti-infectives market is further categorized by product type, including antibacterial, antifungal, antivirals, and antiparasitics. Among these, the antibacterial segment holds the largest market share, accounting for 44.3% in 2023, and is expected to remain the leading category. This is due to the critical role antibiotics play in addressing bacterial infections in both livestock and companion animals. The growing prevalence of bacterial diseases and the ongoing challenges posed by antibiotic resistance highlight the importance of continuous innovation and research in developing antibacterial treatments.

In North America, the veterinary anti-infectives market is poised for significant growth, with the U.S. contributing USD 2 billion in 2023. Factors such as a well-established healthcare infrastructure, heavy investment in research and development, and a high incidence of infectious diseases in humans and animals support the market's expansion. The U.S. also benefits from a strict regulatory framework that ensures the safety and efficacy of anti-infective products, further encouraging industry growth. Increasing pet ownership and rising demand for livestock products continue to drive the need for veterinary anti-infectives, making the U.S. a key player in the global market.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidence of zoonotic diseases among animals
    • 3.2.1.2 Growing advancements in veterinary medicines
    • 3.2.1.3 Increasing demand for meat and animal products
    • 3.2.1.4 Growing government initiatives to control animal diseases
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Rising concerns over antibiotic resistance
    • 3.2.2.2 Stringent regulatory challenges
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pipeline analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Livestock animals
  • 5.2.1 Cattle
  • 5.2.2 Poultry
  • 5.2.3 Swine
  • 5.2.4 Other livestock animals
• 5.3 Companion animals
  • 5.3.1 Dogs
  • 5.3.2 Cats
  • 5.3.3 Other companion animals

Chapter 6 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Antibacterial
• 6.3 Antifungal
• 6.4 Antivirals
• 6.5 Antiparasitics

Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Oral
• 7.3 Parenteral
• 7.4 Topical
• 7.5 Other routes of administration

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Retail pharmacies
• 8.3 Online pharmacies
• 8.4 Veterinary hospital pharmacies

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Aspen Veterinary Resources
• 10.2 Boehringer Ingelheim International
• 10.3 Ceva
• 10.4 Dechra Pharmaceuticals
• 10.5 Elanco
• 10.6 Merck & Co
• 10.7 Norbrook
• 10.8 Phibro Animal Health
• 10.9 Vetoquinol S.A.
• 10.10 Virbac
• 10.11 Zoetis